Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXTERA SURGICAL INCDXTR · Entity 174504 | V.P., Finance, CFO, Secretary | May 16, 2017 | May 18, 2017 |
| Peraso Inc.PRSO · Entity 8062 | Director | January 07, 2026 | January 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXTERA SURGICAL INC
Report date May 16, 2017 · Filed May 18, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series B Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.27 | IndirectBy Family Trust. | 25 |
Reported balance
After 2017-05-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-16 · Purchase · Acquired 25 · Balance 25 F1: Each share of Series B convertible preferred stock was sold with warrants to purchase up to 3,704 shares of common stock (referred to as "Series 1 warrants") and warrants to purchase up to 1,852 shares of common stock (referred to as "Series 2 warrants"). F2: Subject to certain ownership limitations, each share of the Series B convertible preferred stock is convertible at any time at the option of the holder into 3,704 shares of common stock. F3: There is no expiration date. |
| Series 1 Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.27 | IndirectBy Family Trust. | 92,600 |
Reported balance
After 2017-05-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-05-16 · Purchase · Acquired 92,600 · Balance 92,600 F7: The reported securities are included in the price equal to $1,000 per share of the Series B convertible preferred stock purchased. F4: Subject to certain ownership limitations, the warrants are immediately exercisable. F5: The warrant expires on the fifth anniversary of the date of issuance. |
| Series 2 Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.27 | IndirectBy Family Trust. | 46,300 |
Reported balance
After 2017-05-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-05-16 · Purchase · Acquired 46,300 · Balance 46,300 F7: The reported securities are included in the price equal to $1,000 per share of the Series B convertible preferred stock purchased. F4: Subject to certain ownership limitations, the warrants are immediately exercisable. F6: The warrant expires on the first anniversary of the date of issuance. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Series B convertible preferred stock was sold with warrants to purchase up to 3,704 shares of common stock (referred to as "Series 1 warrants") and warrants to purchase up to 1,852 shares of common stock (referred to as "Series 2 warrants").
F2: Subject to certain ownership limitations, each share of the Series B convertible preferred stock is convertible at any time at the option of the holder into 3,704 shares of common stock.
F3: There is no expiration date.
F4: Subject to certain ownership limitations, the warrants are immediately exercisable.
F5: The warrant expires on the fifth anniversary of the date of issuance.
F6: The warrant expires on the first anniversary of the date of issuance.
F7: The reported securities are included in the price equal to $1,000 per share of the Series B convertible preferred stock purchased.
Peraso Inc.
Report date January 07, 2026 · Filed January 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,947 |
Reported balance
After 2026-01-07 transaction · row 1
1 source rowRow 1 · 2026-01-07 · Grant · Acquired 50,000 · Balance 53,947 F1: Restricted Stock Unit ("RSU") award granted on January 7, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The entire award vests and becomes non-forfeitable on January 7, 2027, or, if earlier, the date of the next annual meeting of stockholders of the Issuer following January 7, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit ("RSU") award granted on January 7, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The entire award vests and becomes non-forfeitable on January 7, 2027, or, if earlier, the date of the next annual meeting of stockholders of the Issuer following January 7, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARI NETWORK SERVICES INC /WI
Report date August 29, 2017 · Filed August 31, 2017
Section 16 reporting ended · disclosed 2017-08-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-29 transaction · row 1
1 source rowRow 1 · 2017-08-29 · Disposition to issuer · Disposed 77,446 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated June 20, 2017 among the Issuer, Expedition Holdings LLC ("Parent") and Expedition Merger Sub, Inc., at the effective time (the "Effective Time") of the merger (the "Merger") contemplated under the Merger Agreement, each unvested share of restricted stock of the Issuer vested, and each share of Issuer common stock converted into the right to receive $7.10 in cash. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2022-11-06 | Direct | 0 |
Reported balance
After 2017-08-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-29 · Disposition to issuer · Disposed 10,000 · Balance 0 F2: At the Effective Time of the Merger, outstanding options to purchase shares of Issuer common stock were cancelled and converted into the right to receive, for each share of Issuer common stock subject to the option, an amount in cash equal to (x) $7.10, minus (y) the sum of (1) the exercise price per share of common stock of such option, and (2) any applicable withholding amounts. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated June 20, 2017 among the Issuer, Expedition Holdings LLC ("Parent") and Expedition Merger Sub, Inc., at the effective time (the "Effective Time") of the merger (the "Merger") contemplated under the Merger Agreement, each unvested share of restricted stock of the Issuer vested, and each share of Issuer common stock converted into the right to receive $7.10 in cash.
F2: At the Effective Time of the Merger, outstanding options to purchase shares of Issuer common stock were cancelled and converted into the right to receive, for each share of Issuer common stock subject to the option, an amount in cash equal to (x) $7.10, minus (y) the sum of (1) the exercise price per share of common stock of such option, and (2) any applicable withholding amounts.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | Peraso Inc. PRSO · Entity 8062 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-002988 · ownership.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,947 F1 · shares: Restricted Stock Unit ("RSU") award granted on January 7, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The entire award vests and becomes non-forfeitable on January 7, 2027, or, if earlier, the date of the next annual meeting of stockholders of the Issuer following January 7, 2026. Read SEC document |
| January 17, 2025 Filed Jan 24, 2025 01:38 UTC | Peraso Inc. PRSO · Entity 8062 | GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-006141 · ownership.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,947 F1 · shares: Restricted Stock Unit ("RSU") award granted on January 17, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The entire award vests and becomes non-forfeitable on January 17, 2026, or, if earlier, the date of the next annual meeting of stockholders of the Issuer following January 17, 2025. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:30 UTC | Peraso Inc. PRSO · Entity 8062 | GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-018519 · ownership.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,447 F1 · shares: Restricted Stock Unit ("RSU") award granted on February 27, 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The entire award vests and becomes non-forfeitable on February 27, 2025, or, if earlier, the date of the next annual meeting of stockholders of the Issuer following February 27, 2024. Read SEC document |
| February 03, 2023 Filed Feb 8, 2023 02:22 UTC | Peraso Inc. PRSO · Entity 8062 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-009088 · ownership.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,862 F1 · shares: Restricted Stock Unit ("RSU") award granted on February 3, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The entire award vests and becomes non-forfeitable on February 3, 2024, or, if earlier, the date of the next annual meeting of stockholders of the Issuer following February 3, 2023. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:41 UTC | Peraso Inc. PRSO · Entity 8062 | PurchaseCommon Stock | 7,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-038109 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,862 F1 · price: Securities acquired have a weighted average price of $1.81. Read SEC document |
| May 23, 2022 Filed May 23, 2022 22:39 UTC | Peraso Inc. PRSO · Entity 8062 | PurchaseCommon Stock | 10,000 | $1.65 | $16,500.00 |
DisclosureSEC source: 0001209191-22-031455 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,862 Read SEC document |
| May 13, 2022 Filed May 17, 2022 22:26 UTC | Peraso Inc. PRSO · Entity 8062 | PurchaseCommon Stock | 3,000 | $1.88 | $5,640.00 |
DisclosureSEC source: 0001209191-22-029844 · doc4.xml · nonDerivative · entry 2 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,862 Read SEC document |
| May 12, 2022 Filed May 17, 2022 22:26 UTC | Peraso Inc. PRSO · Entity 8062 | PurchaseCommon Stock | 10,000 | $1.63 | $16,300.00 |
DisclosureSEC source: 0001209191-22-029844 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,862 Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 00:51 UTC | Peraso Inc. PRSO · Entity 8062 | PurchaseCommon Stock | 10,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019009 · doc4.xml · nonDerivative · entry 3 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,862 F3 · price: Securities acquired range from $2.06 to $2.15, with a weighted average price of $2.10. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 00:51 UTC | Peraso Inc. PRSO · Entity 8062 | PurchaseCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019009 · doc4.xml · nonDerivative · entry 2 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,462 F2 · price: Securities acquired range from $2.12 to $2.15, with a weighted average price of $2.13. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 00:51 UTC | Peraso Inc. PRSO · Entity 8062 | PurchaseCommon Stock | 4,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019009 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,462 F1 · price: Securities acquired range from $2.15 to $2.20, with a weighted average price of $2.17. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 15:36 UTC | Peraso Inc. PRSO · Entity 8062 | GrantStock Option (right to buy) · Derivative | 19,724 | $5.07 Strike: $5.07 | $100,000.68 |
DisclosureSEC source: 0001209191-21-071031 · doc4.xml · derivative · entry 2 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,724 Underlying: Common Stock · 19,724 shares Expires 2031-12-22 F2 · derivative.exercise_date: One-third of the shares subject to the option vests on the first annual anniversary of the grant, and the remaining shares vest quarterly over the subsequent two years. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 15:36 UTC | Peraso Inc. PRSO · Entity 8062 | GrantCommon Stock | 9,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071031 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,862 F1 · shares: Restricted Stock Unit ("RSU") award granted on December 22, 2021. Each RSU represents a contingent right to receive one share of the Registrant's common stock once vested. The entire award vests and becomes non-forfeitable on December 22, 2022, or, if earlier, the next annual meeting of stockholders of the Registrant following December 22, 2021. Read SEC document |
| December 13, 2021 Filed Dec 14, 2021 13:41 UTC | Peraso Inc. MOSY · Entity 8062 | PurchaseCommon stock | 15,000 | $4.04 | $60,600.00 |
DisclosureSEC source: 0001209191-21-069364 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 F1 · price: Price of securities acquired ranged from $3.98 to $4.09, with an average price of $4.04. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 19:00 UTC | Peraso Inc. MOSY · Entity 8062 | GrantRestricted Stock Units | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-067482 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · security: Restricted Stock Unit ("RSU") award granted on December 1, 2021. Each RSU represents a contingent right to receive one share of the Company's common stock once vested. The entire award vests and becomes non-forfeitable on December 1, 2022, or, if earlier, the next annual meeting of stockholders following December 1, 2021, subject to reporting person's continuous service with the Company. F1 · price: Restricted Stock Unit ("RSU") award granted on December 1, 2021. Each RSU represents a contingent right to receive one share of the Company's common stock once vested. The entire award vests and becomes non-forfeitable on December 1, 2022, or, if earlier, the next annual meeting of stockholders following December 1, 2021, subject to reporting person's continuous service with the Company. F2 · balance_after: In accordance with Instruction 4 to this Form, Column 5 reports only the total beneficial ownership of the "class" of derivative security reported in Column 1. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 18:39 UTC | Peraso Inc. MOSY · Entity 8062 | GrantRestricted Stock | 1,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-044206 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · security: Restricted Stock Unit ("RSU") award granted on July 29, 2020. Each RSU represents a contingent right to receive one share of the Company's common stock once vested. The entire award vests and becomes non-forfeitable on July 29, 2021, or, if earlier, the date of the next annual meeting of stockholders following the Grant Date, subject to reporting person's continuous service with the Company. F1 · price: Restricted Stock Unit ("RSU") award granted on July 29, 2020. Each RSU represents a contingent right to receive one share of the Company's common stock once vested. The entire award vests and becomes non-forfeitable on July 29, 2021, or, if earlier, the date of the next annual meeting of stockholders following the Grant Date, subject to reporting person's continuous service with the Company. F2 · balance_after: In accordance with Instruction 4 to this Form, Column 5 reports only the total beneficial ownership of the "class" of derivative security reported in Column 1. Read SEC document |
| May 07, 2020 Filed May 11, 2020 23:12 UTC | Peraso Inc. MOSY · Entity 8062 | PurchaseCommon Stock | 10,000 | $1.40 | $14,000.00 |
DisclosureSEC source: 0001209191-20-028387 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Read SEC document |
| October 23, 2019 Filed Oct 25, 2019 19:16 UTC | Peraso Inc. MOSY · Entity 8062 | GrantRestricted Stock Units | 1,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-025961 · doc4.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: Restricted Stock Unit ("RSU") award granted on October 23, 2019. Each RSU represents a contingent right to receive one share of the Company's common stock once vested. The entire award vests and becomes non-forfeitable on August 23, 2020, or, if earlier, the next annual meeting of stockholders following October 23, 2019, subject to reporting person's continuous service with the Company. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 23:55 UTC | Peraso Inc. MOSY · Entity 8062 | GrantRestricted Stock Units | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001645383-19-000009 · primary_doc.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · price: Restricted Stock Unit ("RSU") award granted February 6, 2019. Each RSU represents a contingent right to receive one share of the Company's common stock once vested. The entire award vests and becomes non-forfeitable on February 6, 2020. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 20:22 UTC | Peraso Inc. MOSY · Entity 8062 | Disposition to issuerOption to purchase Common Stock · Derivative | 100,000 | $0.19 Strike: $0.19 | $18,600.00 |
DisclosureSEC source: 0001645383-19-000001 · primary_doc.xml · derivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2025-01-07 F1 · security: Options vest on each anniversary of October 12, 2018 at the rate of 1/3 of the total number of shares subject to the option Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 16:43 UTC | Peraso Inc. MOSY · Entity 8062 | PurchaseCommon Stock | 50,000 | $0.22 | $10,925.00 |
DisclosureSEC source: 0001645383-18-000016 · primary_doc.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Read SEC document |
| August 29, 2017 Filed Aug 31, 2017 10:38 UTC | ARI NETWORK SERVICES INC /WI ARIS · Entity 173498 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0000892712-17-000668 · edgar.xml · derivative · entry 2 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stcok · 10,000 shares Expires 2022-11-06 F2 · kind: At the Effective Time of the Merger, outstanding options to purchase shares of Issuer common stock were cancelled and converted into the right to receive, for each share of Issuer common stock subject to the option, an amount in cash equal to (x) $7.10, minus (y) the sum of (1) the exercise price per share of common stock of such option, and (2) any applicable withholding amounts. F2 · price: At the Effective Time of the Merger, outstanding options to purchase shares of Issuer common stock were cancelled and converted into the right to receive, for each share of Issuer common stock subject to the option, an amount in cash equal to (x) $7.10, minus (y) the sum of (1) the exercise price per share of common stock of such option, and (2) any applicable withholding amounts. Read SEC document |
| August 29, 2017 Filed Aug 31, 2017 10:38 UTC | ARI NETWORK SERVICES INC /WI ARIS · Entity 173498 | Disposition to issuerCommon Stock | 77,446 | $7.10 | $549,866.60 |
DisclosureSEC source: 0000892712-17-000668 · edgar.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated June 20, 2017 among the Issuer, Expedition Holdings LLC ("Parent") and Expedition Merger Sub, Inc., at the effective time (the "Effective Time") of the merger (the "Merger") contemplated under the Merger Agreement, each unvested share of restricted stock of the Issuer vested, and each share of Issuer common stock converted into the right to receive $7.10 in cash. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 15:48 UTC | ARI NETWORK SERVICES INC /WI ARIS · Entity 173498 | GiftCommon Stock | 13,900 | $0.00 | $0.00 |
DisclosureSEC source: 0000892712-17-000651 · edgar.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,446 Read SEC document |
| May 16, 2017 Filed May 18, 2017 21:42 UTC | DEXTERA SURGICAL INC DXTR · Entity 174504 | PurchaseSeries 2 Convertible Preferred Stock · Derivative | 46,300 | Not disclosed Strike: $0.27 | Not disclosed |
DisclosureSEC source: 0001437749-17-009605 · rdgdoc.xml · derivative · entry 3 Newell Robert Y IV · CIK 0001347183 · V.P., Finance, CFO, Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust. Disclosed balance after: 46,300 Underlying: Common Stock · 46,300 shares Expires not disclosed F7 · price: The reported securities are included in the price equal to $1,000 per share of the Series B convertible preferred stock purchased. F4 · derivative.exercise_date: Subject to certain ownership limitations, the warrants are immediately exercisable. F6 · derivative.expiration_date: The warrant expires on the first anniversary of the date of issuance. Read SEC document |
| May 16, 2017 Filed May 18, 2017 21:42 UTC | DEXTERA SURGICAL INC DXTR · Entity 174504 | PurchaseSeries 1 Convertible Preferred Stock · Derivative | 92,600 | Not disclosed Strike: $0.27 | Not disclosed |
DisclosureSEC source: 0001437749-17-009605 · rdgdoc.xml · derivative · entry 2 Newell Robert Y IV · CIK 0001347183 · V.P., Finance, CFO, Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust. Disclosed balance after: 92,600 Underlying: Common Stock · 92,600 shares Expires not disclosed F7 · price: The reported securities are included in the price equal to $1,000 per share of the Series B convertible preferred stock purchased. F4 · derivative.exercise_date: Subject to certain ownership limitations, the warrants are immediately exercisable. F5 · derivative.expiration_date: The warrant expires on the fifth anniversary of the date of issuance. Read SEC document |
| May 16, 2017 Filed May 18, 2017 21:42 UTC | DEXTERA SURGICAL INC DXTR · Entity 174504 | PurchaseSeries B Convertible Preferred Stock · Derivative | 25 | $1,000.00 Strike: $0.27 | $25,000.00 |
DisclosureSEC source: 0001437749-17-009605 · rdgdoc.xml · derivative · entry 1 Newell Robert Y IV · CIK 0001347183 · V.P., Finance, CFO, Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust. Disclosed balance after: 25 Underlying: Common Stock · 92,600 shares Expires not disclosed F1 · security: Each share of Series B convertible preferred stock was sold with warrants to purchase up to 3,704 shares of common stock (referred to as "Series 1 warrants") and warrants to purchase up to 1,852 shares of common stock (referred to as "Series 2 warrants"). F2 · derivative.exercise_date: Subject to certain ownership limitations, each share of the Series B convertible preferred stock is convertible at any time at the option of the holder into 3,704 shares of common stock. F3 · derivative.expiration_date: There is no expiration date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 18:00 UTC | DEXTERA SURGICAL INC DXTR · Entity 174504 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-002792 · rdgdoc.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · V.P., Finance, CFO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents shares underlying Restricted Stock Units under the Cardica 2016 Equity Incentive Plan. The award vests 100% on 2/15/18. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:49 UTC | ARI NETWORK SERVICES INC /WI ARIS · Entity 173498 | GrantCommon Stock | 5,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000892712-17-000023 · edgar.xml · nonDerivative · entry 1 Newell Robert Y IV · CIK 0001347183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,346 F1 · price: Award of Restricted Stock granted under the Amended and Restated ARI Network Services, Inc. 2010 Equity Incentive Plan. The shares of restricted stock vest 50% on January 10, 2018 and 50% on January 10, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.